scispace - formally typeset
H

Huan Qi

Researcher at Dalian Institute of Chemical Physics

Publications -  34
Citations -  569

Huan Qi is an academic researcher from Dalian Institute of Chemical Physics. The author has contributed to research in topics: Biology & Medicine. The author has an hindex of 8, co-authored 25 publications receiving 179 citations.

Papers
More filters
Journal ArticleDOI

The double-edged roles of ROS in cancer prevention and therapy.

TL;DR: A review of the literature on reactive oxygen species (ROS) and scavenging in cancer is presented in this article, where the authors discuss the related signal transduction networks and corresponding anticancer therapies.
Journal ArticleDOI

BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe

TL;DR: 5-(3, 4, 5-trimethoxybenzoyl)-4-methyl-2-(p-tolyl) imidazol (BZML) displayed potent cytotoxic activity against both A549 and A549/Taxol cells and was a poor substrate for P-glycoprotein (P-gp) and inhibited P-gp function by decreasing P- gp expression at the protein and mRNA levels.
Journal ArticleDOI

USP10 suppresses tumor progression by inhibiting mTOR activation in hepatocellular carcinoma.

TL;DR: The results uncover an undescribed mechanism where USP10, as a tumor suppressor, negatively regulates mTORC1 activation and AKT phosphorylation by stabilizing AMPKα and PTEN in HCC cells.
Journal ArticleDOI

Saikosaponin D from Radix Bupleuri suppresses triple-negative breast cancer cell growth by targeting β-catenin signaling

TL;DR: Investigating the interaction of SSD with the frequently overexpressed targets in TNBC led to the identification that it markedly suppressed Wnt/β-catenin signaling, but did not act on epidermal growth factor receptor and neurotensin receptor-1.
Journal ArticleDOI

F-box proteins and cancer: an update from functional and regulatory mechanism to therapeutic clinical prospects.

TL;DR: The substrates of F-box proteins are summarized, the important molecular mechanism and emerging role of F -box proteins especially from the perspective of cancer development and progression are discussed, and the potential role of E3 ubiquitin ligases as cancer biomarkers and therapeutic targets for future cancer treatment is suggested.